<?xml version="1.0" encoding="UTF-8"?>
<dokument xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://lovdata.no/regelverk" xsi:schemaLocation="lov-eksempel.xsd" id="for-2017-12-06-1987" type="lt" url="https://lovdata.no/lovtidend/forskrift/2017-12-06-1987">
  <metadata>
    <type>lt</type>
    <base>LT</base>
    <id>LT/lt/2017-12-06-1987</id>
    <dato>06.12.2017 nr. 1987</dato>
    <dato type="iso">2017-12-06</dato>
    <ikraft>01.01.2018</ikraft>
    <ikraft type="iso">2018-01-01</ikraft>
    <departement>Helse- og omsorgsdepartementet</departement>
    <etat/>
    <gjelder>Norge</gjelder>
    <hjemmel><ref id="for-2015-06-12-646-§3">F12.06.2015 nr. 646 § 3</ref>, <ref id="for-2015-06-26-1153">F26.06.2015 nr. 1153</ref></hjemmel>
    <endrer type="ref">https://lovdata.no/for/2015-06-12-646</endrer>
    <rettet/>
    <journalnummer>2017-1270</journalnummer>
  </metadata>
  <tekst>
    <korttittel>Endr. i forskrift om helseforetaksfinansierte reseptlegemidler</korttittel>
    <tittel>Forskrift om endring i forskrift om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus</tittel>
    <redaksjonell_note><b>Hjemmel:</b> Fastsatt av Helsedirektoratet 6. desember 2017 med hjemmel i forskrift 12. juni 2015 nr. 646 om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus § 3, jf. delegeringsvedtak 26. juni 2015 nr. 1153.</redaksjonell_note>
    <kapittel type="kapittel" id="/kapittel/i" url="https://lovdata.no/lovtidend/forskrift/2017-12-06-1987/ki">
      <kverdi>I</kverdi>
      <ktittel/>
      <ledd id="/kapittel/i/ledd/1">I forskrift 12. juni 2015 nr. 646 om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus gjøres følgende endring:
<br/></ledd>
      <ledd id="/kapittel/i/ledd/2">Liste over legemidler som skal finansieres av de regionale helseforetakene skal lyde:</ledd>
      <table niv="1" frame="1">
        <thgroup cols="5" rowsep="0" colsep="0">
          <colspec colname="1" align="left" valign="top" colwidth="14*"/>
          <colspec colname="2" align="left" valign="top" colwidth="18*"/>
          <colspec colname="3" align="left" valign="top" colwidth="12*"/>
          <colspec colname="4" align="left" valign="top" colwidth="20*"/>
          <colspec colname="5" align="center" valign="top" colwidth="12*"/>
          <tbody>
            <row>
              <entry colname="1">
                <i>Preparatnavn</i>
              </entry>
              <entry colname="2">
                <i>Virkestoff</i>
              </entry>
              <entry colname="3">
                <i>ATC-kode</i>
              </entry>
              <entry colname="4">
                <i>Bruksområde</i>
              </entry>
              <entry colname="5">
                <i>Dato</i>
              </entry>
            </row>
          </tbody>
        </thgroup>
        <tgroup cols="5" rowsep="0" colsep="0">
          <colspec colname="1" align="left" valign="top" colwidth="14*"/>
          <colspec colname="2" align="left" valign="top" colwidth="18*"/>
          <colspec colname="3" align="left" valign="top" colwidth="12*"/>
          <colspec colname="4" align="left" valign="top" colwidth="20*"/>
          <colspec colname="5" align="center" valign="top" colwidth="12*"/>
          <tbody>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Reslizumab </entry>
              <entry colname="3">R03DX08 </entry>
              <entry colname="4">Alvorlig astma </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Mepolizumab </entry>
              <entry colname="3">R03DX09 </entry>
              <entry colname="4">Alvorlig astma </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Erytropoietin </entry>
              <entry colname="3">B03XA01 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Darbepoetin alfa </entry>
              <entry colname="3">B03XA02 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Metoksypolyetylen-glykol-epoetin beta </entry>
              <entry colname="3">B03XA03 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Humant fibrinogen </entry>
              <entry colname="3">B02BB01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor II, VII, IX og X i kombinasjon </entry>
              <entry colname="3">B02BD01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Faktor VIII-inhibitor bypass-aktivitet </entry>
              <entry colname="3">B02BD03 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Von Willebrands faktor og koagulasjonsfaktor VIII i kombinasjon </entry>
              <entry colname="3">B02BD06 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor XIII </entry>
              <entry colname="3">B02BD07 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Eptacog alfa (aktivert) </entry>
              <entry colname="3">B02BD08 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Von Willebrands faktor </entry>
              <entry colname="3">B02BD10 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Katridekakog </entry>
              <entry colname="3">B02BD11 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor X </entry>
              <entry colname="3">B02BD13 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD14 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Entekavir </entry>
              <entry colname="3">J05AF10 </entry>
              <entry colname="4">Hepatitt B-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Telbivudine </entry>
              <entry colname="3">J05AF11 </entry>
              <entry colname="4">Hepatitt B-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tenofoviralafenamid </entry>
              <entry colname="3">J05AF13 </entry>
              <entry colname="4">Hepatitt B-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Interferon alfa-2a </entry>
              <entry colname="3">L03AB04 </entry>
              <entry colname="4">Hepatitt B- og C-infeksjon, kreft </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Interferon alfa-2b </entry>
              <entry colname="3">L03AB05 </entry>
              <entry colname="4">Hepatitt B- og C-infeksjon, kreft </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Peginterferon alfa-2a </entry>
              <entry colname="3">L03AB11 </entry>
              <entry colname="4">Hepatitt B- og C-infeksjon, kreft </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ribavirin </entry>
              <entry colname="3">J05AP01 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Simeprevir </entry>
              <entry colname="3">J05AP05 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sofosbuvir/velpatasvir/voksilaprevir </entry>
              <entry colname="3">J05AP56 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">15.09.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Glecaprevir/pibrentasvir </entry>
              <entry colname="3">J05AX00 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">15.09.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Daklatasvir </entry>
              <entry colname="3">J05AP07 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sofosbuvir </entry>
              <entry colname="3">J05AP08 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dasabuvir </entry>
              <entry colname="3">J05AP09 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sofosbuvir og ledipasvir </entry>
              <entry colname="3">J05AP51 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ombitasvir, paritaprevir og ritonavir </entry>
              <entry colname="3">J05AP53 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Elbasvir/grazoprevir </entry>
              <entry colname="3">J05AP54 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sofosbuvir/Velpatasvir </entry>
              <entry colname="3">J05AP55 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Peginterferon alfa-2b </entry>
              <entry colname="3">L03AB10 </entry>
              <entry colname="4">Hepatitt C-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sakinavir </entry>
              <entry colname="3">J05AE01 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Indinavir </entry>
              <entry colname="3">J05AE02 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ritonavir </entry>
              <entry colname="3">J05AE03 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Atazanavir </entry>
              <entry colname="3">J05AE08 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tipranavir </entry>
              <entry colname="3">J05AE09 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Darunavir </entry>
              <entry colname="3">J05AE10 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Zidovudin </entry>
              <entry colname="3">J05AF01 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Stavudin </entry>
              <entry colname="3">J05AF04 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Abakavir </entry>
              <entry colname="3">J05AF06 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin </entry>
              <entry colname="3">J05AF09 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Nevirapin </entry>
              <entry colname="3">J05AG01 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Efavirenz </entry>
              <entry colname="3">J05AG03 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Etravirin </entry>
              <entry colname="3">J05AG04 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Rilpivirin </entry>
              <entry colname="3">J05AG05 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lamivudin og zidovudin </entry>
              <entry colname="3">J05AR01 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Abakavir og lamivudin </entry>
              <entry colname="3">J05AR02 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin og tenofovirdisoproksil </entry>
              <entry colname="3">J05AR03 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Abakavir, lamivudin og zidovudin </entry>
              <entry colname="3">J05AR04 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin, tenofovirdisoproksil og efavirenz </entry>
              <entry colname="3">J05AR06 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin, tenofovirdisoproksil og rilpivirin </entry>
              <entry colname="3">J05AR08 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin, tenofovirdisoproksil, elvitegravir og kobicistat </entry>
              <entry colname="3">J05AR09 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lopinavir og ritonavir </entry>
              <entry colname="3">J05AR10 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dolutegravir, abakavir og lamivudin </entry>
              <entry colname="3">J05AR13 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Darunavir og kobicistat </entry>
              <entry colname="3">J05AR14 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Atazanavir og kobicistat </entry>
              <entry colname="3">J05AR15 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin og tenofoviralafenamid </entry>
              <entry colname="3">J05AR17 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin, tenofoviralafenamid, elvitegravir og kobicistat </entry>
              <entry colname="3">J05AR18 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Emtricitabin, tenofoviralafenamid og rilpivirin </entry>
              <entry colname="3">J05AR19 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Inosine pranobex </entry>
              <entry colname="3">J05AX05 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Raltegravir </entry>
              <entry colname="3">J05AX08 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Maraviroc </entry>
              <entry colname="3">J05AX09 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dolutegravir </entry>
              <entry colname="3">J05AX12 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Kobicistat </entry>
              <entry colname="3">V03AX03 </entry>
              <entry colname="4">HIV-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lamivudin </entry>
              <entry colname="3">J05AF05 </entry>
              <entry colname="4">HIV- og hepatitt B-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tenofovirdisoproksil </entry>
              <entry colname="3">J05AF07 </entry>
              <entry colname="4">HIV- og hepatitt B-infeksjon </entry>
              <entry colname="5">01.01.2018 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Filgrastim </entry>
              <entry colname="3">L03AA02 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lipefilgrastim </entry>
              <entry colname="3">L03AA14 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Syklofosfamid </entry>
              <entry colname="3">L01AA01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Klorambucil </entry>
              <entry colname="3">L01AA02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Melfalan </entry>
              <entry colname="3">L01AA03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Klormetin </entry>
              <entry colname="3">L01AA05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ifosfamid </entry>
              <entry colname="3">L01AA06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trofosfamid </entry>
              <entry colname="3">L01AA07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bendamustin </entry>
              <entry colname="3">L01AA09 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Busulfan </entry>
              <entry colname="3">L01AB01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tiotepa </entry>
              <entry colname="3">L01AC01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lomustin </entry>
              <entry colname="3">L01AD02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Temozolomid </entry>
              <entry colname="3">L01AX03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dakarbazin </entry>
              <entry colname="3">L01AX04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Raltitreksed </entry>
              <entry colname="3">L01BA03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pemetrexed </entry>
              <entry colname="3">L01BA04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Merkaptopurin </entry>
              <entry colname="3">L01BB02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Thioguanin </entry>
              <entry colname="3">L01BB03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Fludarabin </entry>
              <entry colname="3">L01BB05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Klofarabin </entry>
              <entry colname="3">L01BB06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Nelarabin </entry>
              <entry colname="3">L01BB07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Cytarabin </entry>
              <entry colname="3">L01BC01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Fluorouracil </entry>
              <entry colname="3">L01BC02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Gemcitabin </entry>
              <entry colname="3">L01BC05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Kapecitabin </entry>
              <entry colname="3">L01BC06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Azacitidin </entry>
              <entry colname="3">L01BC07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Decitabin </entry>
              <entry colname="3">L01BC08 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tegafur </entry>
              <entry colname="3">L01BC53 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trifluridin; Tipiracil </entry>
              <entry colname="3">L01BC59 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vinblastin </entry>
              <entry colname="3">L01CA01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vinkristin </entry>
              <entry colname="3">L01CA02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vinorelbin </entry>
              <entry colname="3">L01CA04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vinflunin </entry>
              <entry colname="3">L01CA05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Etoposid </entry>
              <entry colname="3">L01CB01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Paklitaksel </entry>
              <entry colname="3">L01CD01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Docetaksel </entry>
              <entry colname="3">L01CD02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Kabazitaksel </entry>
              <entry colname="3">L01CD04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trabektedin </entry>
              <entry colname="3">L01CX01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Doksorubicin </entry>
              <entry colname="3">L01DB01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Daunorubicin </entry>
              <entry colname="3">L01DB02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Epirubicin </entry>
              <entry colname="3">L01DB03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Idarubicin </entry>
              <entry colname="3">L01DB06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Mitoksantron </entry>
              <entry colname="3">L01DB07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Piksantron </entry>
              <entry colname="3">L01DB11 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bleomycin </entry>
              <entry colname="3">L01DC01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Mitomycin </entry>
              <entry colname="3">L01DC03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Neratinib </entry>
              <entry colname="3">L01X </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Cisplatin </entry>
              <entry colname="3">L01XA01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Karboplatin </entry>
              <entry colname="3">L01XA02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Oksaliplatin </entry>
              <entry colname="3">L01XA03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Polyplatillen </entry>
              <entry colname="3">L01XA05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Procarbazine </entry>
              <entry colname="3">L01XB01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Atezolizumab </entry>
              <entry colname="3">L01XC </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Avelumab </entry>
              <entry colname="3">L01XC </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.09.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trastuzumab </entry>
              <entry colname="3">L01XC03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Gemtuzumab ozogamicin </entry>
              <entry colname="3">L01XC05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Cetuksimab </entry>
              <entry colname="3">L01XC06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bevacizumab </entry>
              <entry colname="3">L01XC07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Panitumumab </entry>
              <entry colname="3">L01XC08 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Oftumumab </entry>
              <entry colname="3">L01XC10 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ipilimumab </entry>
              <entry colname="3">L01XC11 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Brentuksimabvedotin </entry>
              <entry colname="3">L01XC12 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pertuzumab </entry>
              <entry colname="3">L01XC13 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trastuzumabemtansin </entry>
              <entry colname="3">L01XC14 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Obinutuzumab </entry>
              <entry colname="3">L01XC15 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dinutuksimab </entry>
              <entry colname="3">L01XC16 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Nivolumab </entry>
              <entry colname="3">L01XC17 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pembrolizumab </entry>
              <entry colname="3">L01XC18 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Blinatumomab </entry>
              <entry colname="3">L01XC19 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">ramucirumab </entry>
              <entry colname="3">L01XC21 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Necitumumab </entry>
              <entry colname="3">L01XC22 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Elotuzumab </entry>
              <entry colname="3">L01XC23 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Daratumumab </entry>
              <entry colname="3">L01XC24 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Inotuzumab ozogamicin </entry>
              <entry colname="3">L01XC26 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Olaratumab </entry>
              <entry colname="3">L01XC27 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Metylaminolevulinat </entry>
              <entry colname="3">L01XD03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Aminolevulinsyre </entry>
              <entry colname="3">L01XD04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Padeliporfin </entry>
              <entry colname="3">L01XD07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Acalabrutinib </entry>
              <entry colname="3">L01XE </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pacritinib </entry>
              <entry colname="3">L01XE </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Imatinib </entry>
              <entry colname="3">L01XE01 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Gefitinib </entry>
              <entry colname="3">L01XE02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Erlotinib </entry>
              <entry colname="3">L01XE03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sunitinib </entry>
              <entry colname="3">L01XE04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sorafenib </entry>
              <entry colname="3">L01XE05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dasatinib </entry>
              <entry colname="3">L01XE06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lapatinib </entry>
              <entry colname="3">L01XE07 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Nilotinib </entry>
              <entry colname="3">L01XE08 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Temsirolimus </entry>
              <entry colname="3">L01XE09 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Everolimus </entry>
              <entry colname="3">L01XE10 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pazopanib </entry>
              <entry colname="3">L01XE11 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vandetanib </entry>
              <entry colname="3">L01XE12 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Afatinib </entry>
              <entry colname="3">L01XE13 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bosutinib </entry>
              <entry colname="3">L01XE14 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vemurafenib </entry>
              <entry colname="3">L01XE15 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Krizotinib </entry>
              <entry colname="3">L01XE16 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Aksitinib </entry>
              <entry colname="3">L01XE17 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ruxolitinib </entry>
              <entry colname="3">L01XE18 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Regorafenib </entry>
              <entry colname="3">L01XE21 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dabrafenib </entry>
              <entry colname="3">L01XE23 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ponatinib </entry>
              <entry colname="3">L01XE24 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Trametinib </entry>
              <entry colname="3">L01XE25 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Kabozantinib </entry>
              <entry colname="3">L01XE26 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ibrutinib </entry>
              <entry colname="3">L01XE27 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ceritinib </entry>
              <entry colname="3">L01XE28 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lenvatinib </entry>
              <entry colname="3">L01XE29 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Vargatef </entry>
              <entry colname="2">Nintedanib </entry>
              <entry colname="3">L01XE31 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Cediranib </entry>
              <entry colname="3">L01XE32 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Palbociklib </entry>
              <entry colname="3">L01XE33 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tivozanib </entry>
              <entry colname="3">L01XE34 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Osinertinib </entry>
              <entry colname="3">L01XE35 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Alectinib </entry>
              <entry colname="3">L01XE36 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Cobimetinib </entry>
              <entry colname="3">L01XE38 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Midostaurin </entry>
              <entry colname="3">L01XE39 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Binimetinib </entry>
              <entry colname="3">L01XE41 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ribociclib </entry>
              <entry colname="3">L01XE42 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Brigatinib </entry>
              <entry colname="3">L01XE43 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Asparaginase </entry>
              <entry colname="3">L01XX02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Hydroksykarbamid </entry>
              <entry colname="3">L01XX05 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tretinoin </entry>
              <entry colname="3">L01XX14 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Topotekan </entry>
              <entry colname="3">L01XX17 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Irinotekan </entry>
              <entry colname="3">L01XX19 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Alitretinoin </entry>
              <entry colname="3">L01XX22 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Mitotane </entry>
              <entry colname="3">L01XX23 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pegaspargase </entry>
              <entry colname="3">L01XX24 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Beksaroten </entry>
              <entry colname="3">L01XX25 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Arsentrioksid </entry>
              <entry colname="3">L01XX27 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bortezomib </entry>
              <entry colname="3">L01XX32 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Anagrelid </entry>
              <entry colname="3">L01XX35 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vorinostat </entry>
              <entry colname="3">L01XX38 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.09.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Eribulin </entry>
              <entry colname="3">L01XX41 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Panobinostat </entry>
              <entry colname="3">L01XX42 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vismodegib </entry>
              <entry colname="3">L01XX43 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Aflibercept </entry>
              <entry colname="3">L01XX44 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Karfilzomib </entry>
              <entry colname="3">L01XX45 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Olaparib </entry>
              <entry colname="3">L01XX46 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Idelalisib </entry>
              <entry colname="3">L01XX47 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sonidegib </entry>
              <entry colname="3">L01XX48 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ixazomib </entry>
              <entry colname="3">L01XX50 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Talimogenlaherparepvek </entry>
              <entry colname="3">L01XX51 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Venetoclax </entry>
              <entry colname="3">L01XX52 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Vosaroxin </entry>
              <entry colname="3">L01XX53 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Niraparib </entry>
              <entry colname="3">L01XX54 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Rucaparib </entry>
              <entry colname="3">L01XX55 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Plitidepsin </entry>
              <entry colname="3">L01XX57 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Enzalutamid </entry>
              <entry colname="3">L02BB04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Abirateronacetat </entry>
              <entry colname="3">L02BX03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ropeginterferon alfa-2b </entry>
              <entry colname="3">L03AB15 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Thalidomid </entry>
              <entry colname="3">L04AX02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Lenalidomid </entry>
              <entry colname="3">L04AX04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Pomalidomid </entry>
              <entry colname="3">L04AX06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Bondronat </entry>
              <entry colname="2">Ibandronsyre </entry>
              <entry colname="3">M05BA06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2009 </entry>
            </row>
            <row>
              <entry colname="1">Xgeva </entry>
              <entry colname="2">Denosumab </entry>
              <entry colname="3">M05BX04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Kladribin </entry>
              <entry colname="3">L01BB04 </entry>
              <entry colname="4">Kreftsykdommer og multippel sklerose </entry>
              <entry colname="5">01.05.2017 </entry>
            </row>
            <row>
              <entry colname="1">Qizenday </entry>
              <entry colname="2">D-biotin (vit H) </entry>
              <entry colname="3">A11HA05 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Interferon beta-1a </entry>
              <entry colname="3">L03AB07 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Interferon beta-1b </entry>
              <entry colname="3">L03AB08 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Peginterferon beta-1a </entry>
              <entry colname="3">L03AB13 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.12.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Glatirameracetat </entry>
              <entry colname="3">L03AX13 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Fingolimod </entry>
              <entry colname="3">L04AA27 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">15.07.2011 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Teriflunomid </entry>
              <entry colname="3">L04AA31 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Alemtuzumab </entry>
              <entry colname="3">L04AA34 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Daklizumab </entry>
              <entry colname="3">L04AC01 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dimetylfumarat </entry>
              <entry colname="3">N07XX09 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Laquinimod </entry>
              <entry colname="3">N07XX10 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Epoprostenol </entry>
              <entry colname="3">B01AC09 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Ventavis </entry>
              <entry colname="2">Iloprost </entry>
              <entry colname="3">B01AC11 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Treprostinil </entry>
              <entry colname="3">B01AC21 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Seleksipag </entry>
              <entry colname="3">B01AC27 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Bosentan </entry>
              <entry colname="3">C02KX01 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ambrisentan </entry>
              <entry colname="3">C02KX02 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Macitentan </entry>
              <entry colname="3">C02KX04 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Riociguat </entry>
              <entry colname="3">C02KX05 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Granpidam </entry>
              <entry colname="2">Sildenafil </entry>
              <entry colname="3">G04BE03 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.12.2017 </entry>
            </row>
            <row>
              <entry colname="1">Mysildecard </entry>
              <entry colname="2">Sildenafil </entry>
              <entry colname="3">G04BE03 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Orisild </entry>
              <entry colname="2">Sildenafil </entry>
              <entry colname="3">G04BE03 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Revatio </entry>
              <entry colname="2">Sildenafil </entry>
              <entry colname="3">G04BE03 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Adcirca </entry>
              <entry colname="2">Tadalafil </entry>
              <entry colname="3">G04BE08 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Tadalafil Accord </entry>
              <entry colname="2">Tadalafil </entry>
              <entry colname="3">G04BE08 </entry>
              <entry colname="4">Pulmonal arteriell hypertensjon </entry>
              <entry colname="5">01.01.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Abatacept </entry>
              <entry colname="3">L04AA24 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.04.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tofacitinib </entry>
              <entry colname="3">L04AA29 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.01.2013 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Baricitinib </entry>
              <entry colname="3">L04AA37 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Certolicumab pegol </entry>
              <entry colname="3">L04AB05 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">25.01.2010 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Anakinra </entry>
              <entry colname="3">L04AC03 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Tocilizumab </entry>
              <entry colname="3">L04AC07 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sarilumab </entry>
              <entry colname="3">L04AC14 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Sirukumab </entry>
              <entry colname="3">L04AC15 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">15.07.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Apremilast </entry>
              <entry colname="3">L04AA32 </entry>
              <entry colname="4">Revmatologiske sykdommer og hudsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Etanercept </entry>
              <entry colname="3">L04AB01 </entry>
              <entry colname="4">Revmatologiske sykdommer og hudsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ustekinumab </entry>
              <entry colname="3">L04AC05 </entry>
              <entry colname="4">Revmatologiske sykdommer og hudsykdommer </entry>
              <entry colname="5">01.08.2009 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Secukinumab </entry>
              <entry colname="3">L04AC10 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Brodalumab </entry>
              <entry colname="3">L04AC12 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Ixekizumab </entry>
              <entry colname="3">L04AC13 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Guselkumab </entry>
              <entry colname="3">L04AC16 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.09.2017 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Dimetylfumarat </entry>
              <entry colname="3">N07XX09 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Rituksimab </entry>
              <entry colname="3">L01XC02 </entry>
              <entry colname="4">Revmatologiske sykdommer og kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Infliksimab </entry>
              <entry colname="3">L04AB02 </entry>
              <entry colname="4">Revmatologiske sykdommer og mage-tarmsykdommer </entry>
              <entry colname="5">08.12.2009 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Adalimumab </entry>
              <entry colname="3">L04AB04 </entry>
              <entry colname="4">Revmatologiske sykdommer, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Golimumab </entry>
              <entry colname="3">L04AB06 </entry>
              <entry colname="4">Revmatologiske sykdommer, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alle </entry>
              <entry colname="2">Mecasermin </entry>
              <entry colname="3">H01AC03 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
    </kapittel>
    <kapittel type="kapittel" id="/kapittel/ii" url="https://lovdata.no/lovtidend/forskrift/2017-12-06-1987/kii">
      <kverdi>II</kverdi>
      <ktittel/>
      <ledd id="/kapittel/ii/ledd/1">Forskriften trer i kraft 1. januar 2018.</ledd>
    </kapittel>
  </tekst>
</dokument>
